Research Development - Genfit SA (NASDAQ:GNFT) - Alpha Spread

Genfit SA
NASDAQ:GNFT

Watchlist Manager
Genfit SA Logo
Genfit SA
NASDAQ:GNFT
Watchlist
Price: 4.19 USD -3.46% Market Closed
Market Cap: 209.5m USD
Have any thoughts about
Genfit SA?
Write Note

Genfit SA
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genfit SA
Research & Development Peer Comparison

Comparables:
VLA
NANO
IPH
ALERS
OSE

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Genfit SA
NASDAQ:GNFT
Research & Development
-€35.9m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Research & Development
-€93m
CAGR 3-Years
11%
CAGR 5-Years
-29%
CAGR 10-Years
-14%
Nanobiotix SA
PAR:NANO
Research & Development
-€37.1m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-20%
Innate Pharma SA
PAR:IPH
Research & Development
-€47.1m
CAGR 3-Years
-12%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Research & Development
-€5.9m
CAGR 3-Years
-38%
CAGR 5-Years
-33%
CAGR 10-Years
2%
OSE Immunotherapeutics SA
PAR:OSE
Research & Development
-€24.5m
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A

See Also

What is Genfit SA's Research & Development?
Research & Development
-35.9m EUR

Based on the financial report for Dec 31, 2023, Genfit SA's Research & Development amounts to -35.9m EUR.

What is Genfit SA's Research & Development growth rate?
Research & Development CAGR 5Y
9%

Over the last year, the Research & Development growth was -31%. The average annual Research & Development growth rates for Genfit SA have been 11% over the past three years , 9% over the past five years .

Back to Top